Funder
Université de Montréal
Fonds de Recherche du Québec - Santé
Université de Montréal - Faculté de Pharmacie
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference73 articles.
1. Landersdorfer CB, Bulitta JB, Kirkpatrick CM, Kinzig M, Holzgrabe U, Drusano GL, Stephan U, Sörgel F. Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile. Antimicrob Agents Chemother. 2012;56(11):5715–23. https://doi.org/10.1128/AAC.00937-12.
2. Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23(1):160–201. https://doi.org/10.1128/CMR.00037-09.
3. Hayashi Y, Roberts JA, Paterson DL, Lipman J. Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opin Drug Metab Toxicol. 2010;6(8):1017–31. https://doi.org/10.1517/17425255.2010.506187.
4. European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU/EEA: Annual epidemiological report for 2018. 2018. https://www.ecdc.europa.eu/sites/default/files/documents/Antimicrobial-consumption-EU-EEA.pdf.
5. Cotteret C, Vallières E, Roy H, Ovetchkine P, Longtin J, Bussières JF. Antibiotic consumption and bacterial sensitivity in a teaching hospital: a 5-year study [in French]. Arch Pediatr. 2016;23(10):1040–9. https://doi.org/10.1016/j.arcped.2016.07.004.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献